Summary 23
Intestinal inflammation induced with dextran sodium sulfate (DSS) is used to study acute or 24 chronic ulcerative colitis in animal models. Decreased gut tissue anti-inflammatory cytokine IL-25 10 concentration and mRNA abundance are associated with the development of chronic bowel 26 inflammation. Twelve piglets of 3 days old were fitted with an intragastric catheter and 27 randomly allocated into control and DSS groups by administrating either sterile saline or 1.25 g 28 of DSS/kg body weight (BW) in saline per day, respectively, for 10 days. Growth rate and food 29 conversion efficiency were reduced (p<0.05) in the DSS piglets compared with the control 30 group. Quantitative histopathological grading of inflammation in the jejunum and colon 31 collectively showed that the DSS treatment resulted in 12 fold greater (p<0.05) inflammation 32 severity scoring in the colon than in the jejunum, indicative of chronic ulcerative colitis in the 33 colon. Upper gut permeability endpoint was 27.4 fold higher (p<0.05) in the DSS group 34 compared with the control group. The DSS group had higher concentrations and mRNA 35 abundances (p<0.05) of TNF- and IL-6 in the jejunal and colonic tissues compared with the 36 control group. Colonic concentration and mRNA abundance of IL-10 were reduced (p<0.05), 37 however, jejunal IL-10 mRNA abundance was increased (p<0.05) in the DSS group compared 38 with the control group. In conclusion, administration of DSS at 1.25 g/kg BW for 10 days 39 respectively induced acute inflammation in the jejunum and chronic inflammation and ulcerative 40 colitis in the colon with substantially decreased colonic concentration and mRNA abundance of 41 
Results

221
Growth performance 222
The DSS and the control groups of piglets had a similar (p>0.05) initial BW at the 223 beginning of the study (Table 2 ). Both the DSS and the control groups of piglets also consumed 224 a similar (p>0.05) amount of the milk replacer over the course of the experimental period. 225
Despite this, the DSS group had lower (p<0.05) average daily BW gain and gain to food ratio 226 11 11 than the control group (Table 2) Fig. 1A and 1B) . The calculated 233 villous height to crypt depth ratio was lower (p<0.05) in the DSS group in comparison with the 234 control group. In colon, a decrease (p<0.05) in the entire mucosal thickness and an increase 235 (p<0.05) in the smooth muscle thickness were observed in the DSS group compared with the 236 control group (Table 3 ; Fig. 1C and 1D ). Quantitative histopathological grading of inflammation 237 in the jejunum and the colon has been summarized in Table 4 that colonic IL-10 mRNA abundance was decreased to be undetectable, and there was not a trend 265 to reach the threshold even after 45 cycles in the DSS group, while colonic IL-10 mRNA was 266 abundantly expressed in the control group (Table 5) . On the contrary, jejunal IL-10 mRNA 267 abundance was 14 fold higher (p<0.05) in the DSS group than in the control group (Table 5) . 268
When expressed as pg/mg extractable tissue protein for removal of the potentially 269 differential water content effect, the DSS group had higher concentrations (p<0.05) of both TNF-270  and IL-6 cytokines in the jejunal and colonic tissues compared with the control group (Fig. 3) . 271 13 13 Furthermore, TNF- and IL-6 cytokine concentrations (pg/mg extractable tissue protein) were 272 2.9 and 5.4 fold higher (p<0.05) in the colon than in the jejunum within the DSS group. 273
However, no differences (p>0.05) in TNF- and IL-6 cytokine concentrations were observed 274 between the colon and the proximal jejunum within the control group, when these were 275 expressed as pg/mg extractable tissue protein. In addition, there were higher (p<0.05) circulating 276 plasma TNF- and IL-6 cytokine concentrations (pg/mg plasma protein) in the DSS group than 277 in the control group (Fig. 4) . Real time RT-PCR analyses for the cytokine gene expressions 278 revealed higher (p<0.05) mRNA abundances of TNF- and IL-6 in both the jejunal and the 279 colonic tissues in the DSS group compared with the control group (Table 5) . The 2.4 fold dramatic reduction of the IL-10 concentration (Fig. 3) and declining to the 351 undetectable level (Table 5) dramatically reduced to be undetectable in this study (Table 5 ). On the other hand, the jejunal 370 IL-10 mRNA relative abundance was drastically enhanced, in contrast to, the colon within the 371 DSS group in this study (Table 5) and IL-6 concentrations in circulating blood were higher in the DSS group than in the control 389 group (Fig. 4) Furthermore, within the DSS treatment group, the TNF- and IL-6 cytokine levels were much 394 higher in the colonic than in the jejunal tissue (Fig. 3) , suggesting that the DSS administration 395 caused much more severe inflammatory responses in the colon. These results were consistent 396 with the histopathological grading of the proximal jejunum and colon, suggesting that the DSS 397 treatment resulted in considerable transmural inflammatory damage in the colon (Table 4) . Our 398 morphological data in Table 3 showed that the DSS administration and the associated 399 inflammation caused considerable villous atrophy, crypt hyperplasia and stimulated smooth 400 muscle growth, which is not uncommon to the injured gut. 
